Sign in

CIK 0000320017 · Non-accelerated filer<br>Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
222343568
Phone
908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Regulation FD disclosure
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. UPLOAD Other SEC-generated Letter
  5. S-3 Offering Registration Statement
  6. DEFA14A Proxy Proxy Materials
  7. DEF 14A Proxy Proxy Statement
  8. 3 Insider Initial Statement of Ownership
  9. 8-K Event Executive or director change
  10. ARS Other Annual Report to Security Holders
  11. 10-K Report Annual Report
  12. 8-K Event Results of operations · Regulation FD disclosure
  13. 4 Shares withheld for taxes Chief Executive Officer gave up 1,026 shares (to pay taxes)
  14. 4 Shares withheld for taxes EVP, R&D and CMO gave up 5,880 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Executive Officer gave up 23,516 shares (to pay taxes)
  16. 4 Grant or award Director acquired 19,480 shares (grant or award)
  17. 4 Grant or award Director acquired 19,480 shares (grant or award)
  18. 4 Grant or award Director acquired 19,480 shares (grant or award)
  19. 4 Grant or award Director acquired 19,480 shares (grant or award)
  20. 4 Grant or award Director acquired 19,480 shares (grant or award)

Page 6 of 80 · 1,583 filings